Clinical trial NCT00900861: Asthma Control and Clinical Practice in Hungary 2009
Official title: Asthma Control and Clinical Practice in Hungary 2009
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Asthma Control Level
Keywords: asthma control level
visual analogue scale
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2009-05-13
Enrollment: 3000
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Pulmonology outpatient clinics

Brief summary: A prospective study led amongst pulmonologists. Patients asthma control level will be evaluated based on GINA guideline criteria. HRQoL measured by Visual analogue scale. Clinical practice: non controlled patients therapy assessed.


Eligibility criteria: Inclusion Criteria:

* Asthma patients treated with ICS or bronchodilators

Exclusion Criteria:

* COPD
* pulmonary cancer
* pulmonary tuberculosis

Primary outcomes:
measure: Asthma control level
timeFrame: 3 times
Secondary outcomes:
measure: Visual Analogue Scale
timeFrame: 3 times
measure: Routine Therapeutical habits in control maintenance
timeFrame: 3 times
Other outcomes:
Locations:
city: Aszod
country: Hungary
facility: Research Site
city: Bacsalmas
country: Hungary
facility: Research Site
city: Baja
country: Hungary
facility: Research Site
city: Baktaloranthaza
country: Hungary
facility: Research Site
city: Balassagyarmat
country: Hungary
facility: Research Site
city: Bekescsaba
country: Hungary
facility: Research Site
city: Bekes
country: Hungary
facility: Research Site
city: Berettyoujfalu
country: Hungary
facility: Research Site
city: Bonyhad
country: Hungary
facility: Research Site
city: Cegled
country: Hungary
facility: Research Site
city: Celldomolk
country: Hungary
facility: Research Site
city: Csorna
country: Hungary
facility: Research Site
city: Dabas
country: Hungary
facility: Research Site
city: Debrecen
country: Hungary
facility: Research Site
city: Dombovar
country: Hungary
facility: Research Site
city: Dunaharaszti
country: Hungary
facility: Research Site
city: Dunaujvaros
country: Hungary
facility: Research Site
city: Dunavecse
country: Hungary
facility: Research Site
city: Edeleny
country: Hungary
facility: Research Site
city: Eger
country: Hungary
facility: Research Site
city: Encs
country: Hungary
facility: Research Site
city: Erd
country: Hungary
facility: Research Site
city: Esztergom
country: Hungary
facility: Research Site
city: Gavavencsello
country: Hungary
facility: Research Site
city: Godollo
country: Hungary
facility: Research Site
city: Gyorujbarat
country: Hungary
facility: Research Site
city: Gyor
country: Hungary
facility: Research Site
city: Gyungyos
country: Hungary
facility: Research Site
city: Hajdunanas
country: Hungary
facility: Research Site
city: Hatvan
country: Hungary
facility: Research Site
city: Ikreny
country: Hungary
facility: Research Site
city: Jaszbereny
country: Hungary
facility: Research Site
city: Kaposvar
country: Hungary
facility: Research Site
city: Kapuvar
country: Hungary
facility: Research Site
city: Kazincbarcika
country: Hungary
facility: Research Site
city: Keszthely
country: Hungary
facility: Research Site
city: Kisber
country: Hungary
facility: Research Site
city: Kiskoros
country: Hungary
facility: Research Site
city: Kiskunhalas
country: Hungary
facility: Research Site
city: Kistelek
country: Hungary
facility: Research Site
city: Kisvarda
country: Hungary
facility: Research Site
city: Mateszalka
country: Hungary
facility: Research Site
city: Mezokovesd
country: Hungary
facility: Research Site
city: Miskolc
country: Hungary
facility: Research Site
city: Monor
country: Hungary
facility: Research Site
city: Mor
country: Hungary
facility: Research Site
city: Mosonmagyarovar
country: Hungary
facility: Research Site
city: Nagyatad
country: Hungary
facility: Research Site
city: Nagykoros
country: Hungary
facility: Research Site
city: Nyirbator
country: Hungary
facility: Research Site
city: Nyiregyhaza
country: Hungary
facility: Research Site
city: Oroshaza
country: Hungary
facility: Research Site
city: Ozd
country: Hungary
facility: Research Site
city: Papa
country: Hungary
facility: Research Site
city: Paszto
country: Hungary
facility: Research Site
city: Pecs
country: Hungary
facility: Research Site
city: Salgotarjan
country: Hungary
facility: Research Site
city: Sarbogard
country: Hungary
facility: Research Site
city: Savar
country: Hungary
facility: Research Site
city: Siofok
country: Hungary
facility: Research Site
city: Szarvas
country: Hungary
facility: Research Site
city: Szazhalombatta
country: Hungary
facility: Research Site
city: Szecseny
country: Hungary
facility: Research Site
city: Szeged
country: Hungary
facility: Research Site
city: Szekesfehervar
country: Hungary
facility: Research Site
city: Szentendre
country: Hungary
facility: Research Site
city: Szerencs
country: Hungary
facility: Research Site
city: Szolnok
country: Hungary
facility: Research Site
city: Tapolca
country: Hungary
facility: Research Site
city: Tata
country: Hungary
facility: Research Site
city: Tiszalok
country: Hungary
facility: Research Site
city: Tiszaujvaros
country: Hungary
facility: Research Site
city: Torokbalint
country: Hungary
facility: Research Site
city: Vac
country: Hungary
facility: Research Site
city: Vasarosnameny
country: Hungary
facility: Research Site
Study officials:
affiliation: Semmelweis University Budapest Pulmonology Clinic
name: Zoltan Bartfai, MD PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: AstraZeneca Hungary
name: Lilla Szabo
role: STUDY_CHAIR
affiliation: AstraZeneca Hungary
name: Eva Gulyas
role: STUDY_DIRECTOR
References: